Dopamine is named as an intervention in 2 current clinical trials in our Ireland and China registers. 1 is recruiting patients now. The most common phase is Observational. The sponsor with the most trials is Mount Sinai Hospital, Canada (1). The most-studied condition is Late-Onset Neonatal Sepsis.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis
NCT05347238 · Late-Onset Neonatal Sepsis, Extreme Prematurity, Neonatal Hypotension
|
Observational | Recruiting | Mount Sinai Hospital, Canada | Ireland |
|
Vasopressor Agents in Pulmonary Hypertension Crisis
NCT07667829 · ClinicalTrials.gov ↗ · Pulmonary Arterial Hypertension (PAH), Chronic Thromboembolic Pulmonary Hypertension (CTEPH), Hypertension, Pulmonary
|
Not applicable | Not yet open | China National Center for Cardiovascular Diseases | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| Mount Sinai Hospital, Canada | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Ireland | 1 | 1 |
| Clinical trials in China | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
2 current trials in our Ireland and China registers name Dopamine as a drug or biological intervention, as of the registry sync on 25 September 2026. Completed and withdrawn studies are not counted.
Yes. 1 of the 2 trials is recruiting: 1 with sites in Ireland. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Mount Sinai Hospital, Canada (1) and China National Center for Cardiovascular Diseases (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Dopamine works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Dopamine works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Dopamine (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 25 Sep 2026.